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Matrix-assisted laser desorption/ionization (MALDI) tof mass spectrometry was used for the conﬁrmation of hapten number
in synthesized antigen. As application of MAb, the MAbs against ginsenosides and glycyrrhizin have been prepared resulting
in the development of two new techniques that we named the eastern blotting method and the knockout extract preparation.
In eastern blotting technique, glycosides like ginsenosides and glycyrrhizin separated by silica gel TLC were blotted to PVDF
membrane that was treated with a NaIO4 solution followed by BSA resulted in glycoside-BSA conjugate on a PVDF membrane.
The blotted spots were stained by MAb. Double staining of eastern blotting for ginsenosides using antiginsenoside Rb1 and Rg1
MAbs promoted complete identiﬁcation of ginsenosides in Panax species. The immunoaﬃnity concentration of glycyrrhizin was
determined by immunoaﬃnity column conjugated with antiglycyrrhizin MAb resulting in the glycyrrhizin-knockout extract,
which was determined by the synergic eﬀect with glycyrrhizin on NO production using the cell line.
1.Introduction
Immunoassay systems using monoclonal antibody (MAb)
against drugs and small molecular weight bioactive com-
pounds have become an important tool for studies on recep-
tor binding analysis, enzyme assay, and quantitative and/or
qualitative analytical techniques in animals or plants. The
immunoblotting method is based on the western blotting
technique that utilizes the antigen-antibody binding proper-
ties and provides a speciﬁc and sensitive detection of higher
molecule analytes like peptides and proteins. In our ongoing
study on MAb, previously we prepared various kinds of
MAb against natural products like forskolin [1], solamargine
[2], crocin [3], marihuana compounds [4], opium alkaloids
[5], ginsenosides [6, 7], berberine [8], sennosides [9], pae-
oniﬂorin [10], glycyrrhizin [11, 12], ginkgolic acid [13],
aconitine alkaloid [14], baicalin [15] ,a n ds oo na n dd e v e l -
oped individual competitive enzyme-linked immunosorbent
assay(ELISA)asahighlysensitive,speciﬁc,andsimplemeth-
odology.
The conﬁrmation of hapten number in synthesized
antigens is most important in the ﬁrst stage of MAb prepara-
tion. Therefore, its determination method will be discussed
ﬁrst of all. As an application of MAb, the MAb against
ginsenosides and glycyrrhizin has been prepared resulting in
the development of two new techniques that we have named2 International Journal of Analytical Chemistry
the eastern blotting method [12] and the knockout extract
preparation [16]. They will be introduced in this paper.
2.PreparationofMAbagainstNaturalProducts
Various methods have been employed for the determination
of natural products. They include spectral methods such as
infrared (IR), nuclear magnetic resonance (NMR), and cir-
cular dichroism (CD) and other chromatographic methods
such as ion chromatography (IC), capillary electrophoresis
(CE), and high-speed counter current chromatography
(HSCCC), and so on. Compared to TLC, GLC and HPLC
methods, the ELISA method was more sensitive and selec-
tive. Moreover, it is possible to study a large number of
natural products. Since natural product extracts consist of
various chemical constituents (e.g., licorice contains 470
components or more), in general, some pretreatment is
necessary for HPLC and other chromatographic analysis
methods. ELISA, however, can determine the concentration
ofcomponentsdirectlywithoutanypretreatment.Therefore,
ELISA was used to measure the concentration of ginsenoside
Rb1in ginseng and traditional Chinese medicines (TCMs).
2.1. Analytical Method for Determination of Hapten Number
in Antigen, Hapten-Carrier Protein Conjugate. For produc-
tion of MAb, synthesis of hapten, which is derived from an
immune antigen and linker bridge, and the carrier protein
conjugate is necessary. There had been no direct and appro-
priate methods for the determination of haptens conjugated
with carrier proteins without diﬀerential UV analysis, radio-
chemical, or chemical methods. Therefore, immunization
by the injection of hapten-carrier protein conjugate was
unreliable. Wengatz et al. [17] determined the hapten
density of immunoconjugates by matrix-assisted UV laser
desorption/ionization mass spectrometry. We also reported
the direct analytical method of hapten and carrier protein
conjugates by a matrix-assisted laser desorption/ionization
mass spectrometry (MALDI)tof mass spectrometryusing an
internal standard [18–20].
Figure 1showstheMALDItofmassspectrumofthemost
pharmacologically active marihuana compound, tetrahydro-
cannabinolic acid (THCA)-bovine serum albumin (BSA)
conjugate, and BSA used as an internal standard [20]. This
shows only the singly, doubly, and triply ionized molecule
ions of the intact conjugate. The sharp peak at m/z 66,465
is the [M + H]+ peak of BSA. A small [M + H]+ peak of
the THCA-BSA conjugate is at m/z 70,792, indicating that
thecalculatedmolecularmassoftheTHCA-BSAconjugateis
70,581 using a calculated molecular mass of 66,267 for BSA.
The calculated molecule mass of the THCA moiety is 4,314.
Fromthis result,12.7moleculesofTHCA arecombinedwith
BSA [20]. Since this method is suitable for small molecule
natural products, we had been analyzing the hapten number
of all natural products for MAbs including glycosides like
ginsenosides and glycyrrhizin.
2.2. Preparation of MAb against Ginsenosides and ELISA as
an Assay System. Ginseng, the crude drug of Panax ginseng,
is one of the most important natural medicines in many
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Figure 1: Matrix-assisted laser desorption/ionization tof mass
spectrometry of tetrahydrocannabinolic-acid-BSA conjugate. [M +
H] indicates the molecular weight of the conjugate, from which the
hapten number can be calculated.
countries. It has been used to enhance stamina and capacity
to cope with fatigue and physical stress and as a tonic against
cancers, disturbances of the central nervous system (mem-
ory, learning, and behavior), hypothermia, carbohydrate
and lipid metabolism, immune function, the cardiovascular
system, and radioprotection [21]. It contains more than 30
kinds of dammarane and oleanane saponins considered to
be pharmacologically active components. Ginsenoside Rb1 is
the main saponin in ginseng. However, since the concentra-
tion in the ginseng root or the root extract varies depending
on the method of extraction, subsequent treatment, or
even the season of its collection [22], standardization of
quality is required. For this purpose, we have prepared anti-
ginsenoside Rb1 [6]a n dR g 1 MAbs [7]. The immunoassay
system using MAb is not frequently used for naturally
occurring smaller molecular weight bioactive compounds.
Preparation of MAbs is diﬃcult, but is one of the most
important steps for the analysis of natural products. As a
typical natural product, the preparation of MAb against the
ginseng saponin ginsenoside Rb1 will be discussed.
A hybridoma-producing MAb reactive to ginsenoside
Rb1 wasobtainedbythegeneralprocedureandclassiﬁedinto
IgG2b which had κ light chains. The reactivity of IgG type
MAb, 9G7 was tested by varying antibody concentration and
by performing a dilution curve. The antibody concentration
was selected for competitive ELISA. The free MAb following
competition is bound to polystyrene microtiter plates pre-
coated with ginsenoside Rb1-HSA. Under these conditions,
the full measurement range of the assay extends from 20 to
400ng/mL [6].International Journal of Analytical Chemistry 3
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Figure 2: Eastern blotting of ginsenosides in traditional Chinese medicine formulas using anti-ginsenoside Rb1 MAb. Samples
(1) Jigengtang, (2) Dahuanggancaotang, (3) Nenshenyangyongtang, (4) Sijunzitang, (5) Nenshentang, (6) Buanxiaxiexintang, (7)
Xiaocaihutang, and (8) Crude ginseng extract. Lanes 1 and 2 do not contain ginseng. Standard of ginsenosides indicated, ginsenosidr-Rg1,
-Re, -Rd, -Rc, and -Rb1,r e s p e c t i v e l y ,f r o mt h eu p p e rs p o t .
Cross-reactivity is the most important factor in deter-
mining the value of an antibody. Since the ELISA for
ginsenoside Rb1 was established for phytochemical investi-
gations involving crude plant extracts, the assay speciﬁcity
was checked by determining the cross-reactivity of the MAb
with various related compounds. The cross-reactivity data of
MAbthatwasobtainedwereexaminedbycompetitiveELISA
and calculated using picomole amounts of ginsenoside Rb1.
The cross-reactivity of ginsenoside Rc and Rd, which possess
a diglucose moiety attached to the C-3 hydroxy group,
was weak compared to ginsenoside Rb1 (0.024 and 0.020%,
resp.). Ginsenoside Re and Rg1 showed no cross-reactivity
(less than 0.005%). It is evident that the MAb reacted only
with a small number of structurally related ginsenoside Rb1
molecules, and very weakly, and did not react with other
steroidal compounds like glycyrrhizin, digitoxin, tigogenin,
tigonin, and solamargine.
In our ongoing studies on MAbs against ginseng
saponins, anti-ginsenoside Rg1 MAb [7]a n dR e[ 23]h a v e
been prepared and their ELISA was set up. Anti-ginsenoside
Rg1 MAb was also highly speciﬁc like anti-ginsenoside Rb1.
On the other hand, anti-ginsenoside Re MAb showed wide
cross-reactivity. Therefore, the MAb can be used for the
analysis for the total ginsenoside concentration.
2.3. Application of MAb in the Natural Products Field.
Although western blotting is a common assay methodology
for high-molecular-weight-substances, this method has not
been employed for small molecules, as direct immunostain-
ing of such compounds on a TLC plate is as yet unknown.
Therefore, a new method for such small-molecular com-
pounds is required. Moreover, if small molecules can be
blotted to a membrane, ﬁxing them also requires a new
methodology. Previously, we succeeded in separating small-
molecule compounds such as solasodine glycosides into a
part of an epitope and ﬁxing on the membrane [24], as
follows.
2.3.1. New Staining Method for Ginsenosides, “Eastern
Blotting”. Figure 2 shows the H2SO4 staining and eastern
blotting of ginsenoside standards and TCM using anti-
ginsenoside Rb1 MAb. It is impossible to determine the
ginsenosides by TLC staining by H2SO4 as indicated in
Figure 2(a). On the other hand, clear staining of ginseno-
side Rb1 occurred by eastern blotting, as indicated in
Figure 2(b). Furthermore, it became evident that Jigengtang
and Dahuanggancaotang prescriptions that did not contain
ginseng, as indicated by the absence of a ginsenoside
Rb1band. The eastern blotting method was considerably
more sensitive than that of H2SO4 staining. The H2SO4
staining detected all standard compounds. The eastern
blotting indicated only limited staining of ginsenoside Rb1,
Rc, and Rd, whose cross-reactivities were under 0.02%
as shown in Figure 2(b). We suggest that an aglycone,
protopanaxadiol, and a part of the sugars may be of
importance to the immunization and may function as an
epitope for the structure of ginsenosides. In addition, it is
suggested that the speciﬁc reactivity of sugar moieties in the
ginsenosidemoleculeagainstanti-ginsenosideRb1 MAbmay
be modiﬁed by the NaIO4 treatment of ginsenosides on the
PVDF membrane, causing ginsenoside Rc and Rd to become
detectable by eastern blotting.
Application of the eastern blotting method for the detec-
tion of glycyrrhizin in the serum samples was investigated.
In general, it is diﬃcult to detect glycyrrhizin in serum due
to the large amount of impurities. The developed bands
of impurities lapped over the band of glycyrrhizin, and
we failed to ﬁnd a proper developing solvent system that
could separate glycyrrhizin and the impurities apart from
each other clearly on the TLC plate. Figure 3 shows the
detection of glycyrrhizin by the eastern blotting technique in
the rat serum samples. Glycyrrhizin could not be identiﬁed
on the TLC plate stained by H2SO4through many bands that
were detected (Figure 3(a)). On the other hand, eastern
blotting clearly shows the band of glycyrrhizin even after 1h4 International Journal of Analytical Chemistry
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Figure 3: Eastern blotting proﬁle of glycyrrhizin in rat serum after injection of glycyrrhizin (a) TLC of rat-serum-injected glycyrrhizin
TLC was developed with n-BuOH-H2O-AcOH (7:2:1). Spots were detected by 10% H2SO4. (b) Eastern blotting of rat-serum-injected
glycyrrhizin;thebandofglycyrrhizinwasdetecteduntil1hafterinjection.GA:glycyhrrhetinicacid,GC:glycyrrhizin,andGG:glycyrrhetinic
acid monoglucuronide.
(Figure 3(b)). Although the sensitivity of the eastern blotting
method was greatly aﬀected by the impurities, the detection
limit was still at the nanogram level. The results proved that
the eastern blotting technique could be a unique method
for identifying glycyrrhizin against a background of a large
amount of impurities.
Whenthemixtureofanti-ginsenosideRb1 andRg1 MAbs
and the pair of substrates were tested for staining for ginse-
nosides,allginsenosides,ginsenosideRb1 ,-Rc,-Rd,-Re,and
-Rg1 were stained blue although the purple color stain-
ing for ginsenoside Rg1 was expected because 3-amino-9-
ethylcarbazole and 4-chloro-1-naphotol might be diﬀerent.
Therefore, we performed successive staining of the mem-
brane using anti-ginsenoside Rg1 and then anti-ginsenoside
Rb1. Finally, we performed the double staining of gin-
senosides indicating that ginsenoside Rg1 and ginsenoside
Re were stained purple and the other blue, as indicated
in Figure 4. From this result, both antibodies can dis-
tinguish the individual aglycones, protopanaxatriol, and
protopanaxadiol. For this application, the crude extract of
various Panax species was analyzed by the newly developed
double staining system. Major ginsenosides can be deter-
mined clearly by the double staining method, as indicated
in Figure 4.
Therefore,itissuggestedthatthestainingcolorshowsthe
pharmacologicalactivity.AsshowninFigure 4(b),thepurple
bands indicate ginsenosides which have protopanaxatriol as
an aglycone and stimulation activity for the central nervous
system (CNS). On the other hand, the blue color indicates
ginsenosides containing protopanaxadiol as an aglycone
that possess a depression eﬀect on the CNS. Moreover,
the Rf value of ginsenosides roughly suggests the number
of sugars attached to the aglycone. Both analyses make
it possible to jointly identify which aglycone attaches and
how many sugars it possesses, leading to the structure
of the ginsenosides. In fact, three kinds of ginsenosides
possessing protopanaxadiol-ginsenoside Rh1, -Rf, and 20-O-
glucoginsenoside Rf in P. ginseng root were determined by
coloring and Rf value by comparing them with the structures
reported in the previous paper [25].
Figure 5(a) indicates immunolocalization of glycyrrhizin
inalicoricerootsliceusinganti-glycyrrhizinMAbasanother
application of the eastern blotting method. The phloem
(←→) contained a higher concentration of glycyrrhizin than
the xylem and cork part [26]. On the other hand, no staining
occurred on ginseng (Figure 5(c)).
In the earlier experiments, we carried out the blotted
staining on PVDF membrane using MAb on solasodine
glycosides and called it western blotting [24]. Now we
have applied this new methodology to licorice glycoside,
glycyrrhizin and named it eastern blotting [12] for studying
ginsenosides [23], saikosaponin [27], and so on.
2.3.2. Immunoaﬃnity Concentration and One-Step Puriﬁca-
tion of Ginsenoside Rb1 by Immunoaﬃnity Column. Ac r u d e
extract of P. ginseng roots was loaded onto the immunoaﬃn-
ity column and washed with the washing solution of phos-
phate buﬀer. Figure 6 shows the fraction 1–8 containingInternational Journal of Analytical Chemistry 5
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Figure 4: Double Eastern blotting staining of ginsenosides contained in various ginseng samples using anti-ginseenoside-Rb1 and anti-
ginsenoside-Rg1 MAbs. (a) TLC proﬁle stained by sulfuric acid. (b) Eastern blotting by anti-ginsenoside-Rb1 and anti-ginseside-Rg1
monoclonal antibodies I, II, III, IV, V, and VI indicated white ginseng, red ginseng, ﬁbrous ginseng (P. ginseng), P. notoginseng, P.
quinquefolius and P. japonicus, respectively. Upper purple color spots and lower blue color spots were stained by anti-ginsenoside-Rg1,
and anti-ginsenoside-Rb1 monoclonal antibodies, respectively.
(a) (b)
(c) (d)
Figure 5: Immunocytolocalization of glycyrrhizin in fresh licorice
root using anti-glycyrrhizin MAb. (a) Eastern blotting of fresh
licorice slice, (b) fresh licorice slice, (c) Eastern blotting of fresh
ginseng slice, and (d) fresh ginseng slice.
overloaded ginsenoside Rb1. The other ginsenosides Rg1, Rc,
Re. and Rd were also detected in these fractions by eastern
blotting (data not shown). A sharp peak appeared around
fraction 20–24 eluted by acetate buﬀer containing KSCN and
methanol to give pure ginsenoside Rb1.
Overloaded ginsenoside Rb1 was repeatedly immuno-
aﬃnity column choromatographed to separate ginsenoside
Rb1 completely [28]. The antibody was stable when exposed
to the eluent, and the immunoaﬃnity column showed
almost no decrease in capacity after repeated use more than
10 times under the same conditions, as was reported for a
one-step separation of forskolin from a crude extract of
Coleus forskohlii root [29]. This methodology is eﬀective for
therapidandsimplepuriﬁcationofginsenosideRb1 andmay
open up a wide ﬁeld of comparable studies with other fami-
lies of saponins for which an acceptable method for one-step
separation has not yet been developed. Furthermore, to sep-
arate the total ginseng saponins, a wide cross-reactive MAb
against ginsenoside like anti-ginsenoside Re MAb could be
designed, as was done for the total solasodine glycosides
by an immunoaﬃnity column using an anti-solamargine
MAb [30]. A combination of immunoaﬃnity column chro-
matography, Eastern blotting and ELISA could be used to
survey low concentrations of ginsenoside Rb1 of plant origin
and/orinexperimentalanimalsandhumans.Infact,wehave
succeeded in the isolation of ginsenoside Rb1 from a dif-
ferent plant, Kalopanax pictus Nakai, which was not known
previouslytocontainginsenosides,usingthiscombinationof
methods [31].
2.3.3. Newly Established Knockout Extract for Glycyrrhizin.
Glycyrrhizin has been reported to possess numerous phar-
macological eﬀects like anti-inﬂammation [32], antiulcer
[33], antitumor [34], antiallergy [35], and hepatoprotective6 International Journal of Analytical Chemistry
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Figure 6: Elution proﬁle of Panax ginseng crude extract
on immunoaﬃnity column monitoring by ELISA using anti-
ginsenoside-Rb1 MAb.Thecolumnwaswashedbyphosphatebuﬀer
and then eluted by HOAc buﬀer containing KSCN and MeOH.
Individual fractions (2mL) were assayed by ELISA using anti-
ginsenoside-Rb1 MAb.
activities [36]. Although glycyrrhizin is supposed to be
a major active principle in licorice crude extract, a large
numberofstudieshavedemonstratedthatthelicoriceextract
is rich in bioactive compounds other than glycyrrhizin such
as triterpenes, ﬂavonoids, and their aglycones [37]. In order
to conﬁrm the eﬀect of glycyrrhizin in TCM, previously we
puriﬁed glycyrrhizin from TCM using an immunoaﬃnity
column conjugated with anti-glycyrrhizin MAb [38]. In this
section,one-steppuriﬁcationofglycyrrhizinanditsfunction
inthelicoricecrudeextracthavebeenindicatedaspreviously
discussed about ginsenoside Rb1.
To eliminate glycyrrhizin from licorice extract, 12mg
of licorice extract (glycyrrhizin content: 1275.0μg) in
loading buﬀer was applied on the anti-glycyrrhizin MAb
immunoaﬃnity column, and then the loading buﬀer was
continuously circulated through the column to enhance
the binding eﬃciency. After overnight circulation at 4◦C,
the unbound column fraction was collected. The column
was washed, and then bound column fraction was eluted
by elution solvent. Glycyrrhizin concentration of bound
column fraction was 1269.26μg of glycyrrhizin (99.5% of
the loading glycyrrhizin). On the other hand, glycyrrhizin
content of unbound fraction was 3.50μg (0.27% of the load-
ing glycyrrhizin). These data indicated that anti-glycyrrhizin
MAb immunoaﬃnity column could eliminate glycyrrhizin
from licorice crude extract with high eﬃciency. From this
evidence, we named this fraction knockout extract [16, 39].
To further characterize glycyrrhizin knockout extract,
the TLC analysis and eastern blotting were performed. As
shown in Figure 7(a), several spots including glycyrrhizin
were detected in licorice extract. However, the spots of gly-
cyrrhizin were undetected in glycyrrhizin-knockout extract,
although all other spots were clearly detected (Figure 7(a),
lane 2). eastern blotting by anti-glycyrrhizin MAb demon-
strated that glycyrrhizin was detected in licorice extract, but
the spot of glycyrrhizin was invisible in unbound fraction
(Figure 7(b), lane 2). Therefore, these data suggest that
glycyrrhizin was speciﬁcally eliminated from licorice extract
by anti-glycyrrhizin MAb binding immunoaﬃnity column.
This technique is useful approach to clarify the mul-
ticomponent interaction with the speciﬁc protein such as
enzymes, but it is unsuitable to investigate the interaction
between one principal component and other components
in herbal medicines. To investigate the role of one principal
compound in the crude extract, we prepared knockout
extract by removing target compound from the crude extract
using high-speciﬁc MAb immunoaﬃnity column. By using
this approach, it may become possible to determine the
potential function of one natural compound on the crude
extract or TCM by in vitro and in vivo assays.
Nitric oxide (NO) is free radical with multiple physio-
logical functions, such as vasodilatation, neurotransmission,
and inﬂammation [40]. During inﬂammatory process, large
amount of NO is produced by inducible nitric oxide
synthase (iNOS) by inﬂammatory cytokines and/or bacterial
lipopolysaccharide (LPS) in various cell types including
macrophages [41]. Overproduction of NO by iNOS triggers
the pathogenesis of septic shock and organ destruction in
certain inﬂammatory and autoimmune diseases [42–44].
Therefore, the inhibition of NO production by blocking
iNOS expression may be useful strategy for the treatment of
various inﬂammatory diseases.
To determine whether licorice crude extract inhibits NO
productioninLPS-stimulatedmouseRAW264macrophages,
cells were treated with various concentrations of licorice
extract for 30min and then stimulated with LPS. LPS caused
a dramatic increase in NO production, and this induction
wasinhibitedinadose-dependentmannerbytreatmentwith
licorice extract.
We next investigated the inhibitory eﬀect of glycyrrhizin-
knockout extract and the combined treatment with glycyr-
rhizin-knockout extractandglycyrrhizinonNOproduction.
Since 100μg/mL of licorice extract contains 10.6μgo f
glycyrrhizin, the cells were pretreated with licorice extract
(100μg/mL), glycyrrhizin-knockout extract (89.4μg/mL), or
combination of glycyrrhizin-knockout extract (89.4μg/mL)
and glycyrrhizin (10.6μg/mL). Figure 8(a) indicated that
treatment of licorice extract leads to a marked suppression
of NO production as compared to LPS treatment [inhibition
ratio (IR) = 57.7%]. Interestingly, although glycyrrhizin
alonecouldnotblockNOproduction,theinhibitoryeﬀectof
glycyrrhizin-knockout extract was decreased compared with
licorice extract (IR = 17.8%). Moreover, the combined treat-
ment with glycyrrhizin-knockout extract and glycyrrhizin
signiﬁcantly improved the inhibition of NO production
(IR = 33.5%). To determine whether the combinational
eﬀect of glycyrrhizin-knockout extract and glycyrrhizin
was related to iNOS expression, we performed western
blotting (Figure 8(b)). Although the licorice extract stronglyInternational Journal of Analytical Chemistry 7
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Figure 7: Preparation of knock-out extract eliminated glycyrrhizin from licorice crude extract using immunoaﬃnity column conjugated
with anti-glycyrrhizin MAb. Lines 1, 2, and 3 indicate glycyrrhizin, crude extract, and knock-out extract, respectively.
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Figure 8: Eﬀects of glycyrrhizin-knockout extract and the combination of glycyrrhizin-knockout extract and glycyrrhizin on LPS-induced
NO production (a) and iNOS protein expression (b). ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001.
suppressed LPS-induced iNOS expression, treatment of
glycyrrhizin-knockout extract reduced this eﬀect [45].
3. Conclusions
Two unique applications using MAb, eastern blotting and
knockout extract have been introduced in this paper. The
eastern blotting method has great potential applications for
the wide range of natural products, especially glycosides like
ginsenosides of ginseng and glycyrrhizin in licorice. When
two kinds of MAbs, against ginsenoside Rb1 and Rg1 can be
used, the double staining that enhanced the separate staining
of ginsenosides having protopanaxatriol or protopanaxadiol
in a molecule, occurred. The staining color can be used
to monitor the pharmacological activity suggesting that
the purple spots contain protopanaxatriol as an aglycone
indicating central nervous system (CNS) stimulatory activity
[46].Ontheotherhand,thebluecolorindicatesginsenosides
having protopanaxadiol which possess a depression eﬀect on
the CNS [37]. Furthermore, the Rf value of ginsenosides8 International Journal of Analytical Chemistry
suggests the number of sugars attached to the aglycone.
Both evidences make it possible to conﬁrm which aglycone
is attached and how many sugars are combined with the
aglycone.
We demonstrated that knockout extract prepared by
anti-natural compound-speciﬁc MAb immunoaﬃnity col-
umn is a useful approach for determination of potential
function of natural compound on in vitro and in vivo
assays. The pharmacological analysis by knockout extract
might be directly applicable to both other crude extracts and
various TCMs to clarify the real pharmacologically active
components.
A ginsenoside Rb1 knockout extract can be prepared
using an immunoaﬃnity column conjugated with anti-
ginsenoside Rb1 MAb. In this extract, all compounds
except only ginsenoside Rb1 are contained. Furthermore,
glycyrrhizin-knockout extract prepared from licorice crude
extract using an immunoaﬃnity column conjugated with
anti-glycyrrhizin MAb. These knockout extracts may be able
to support the pharmacological investigation for ﬁnding out
a really active component in a crude drug and/or TCM.
In fact, addition of glycyrrhizin to glycyrrhizin-knockout
extract could improve the inhibition of iNOS expression
resulting that glycyrrhizin may exert combinational inhi-
bition of iNOS expression when coexisting with the other
constituents contained in licorice extract.
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